{"disease":{"id":"cold-sores","name":"cold sores"},"drugs":{"marketed":[{"drug_id":"valacyclovir","indication_name":"Cold Sores (Herpes Labialis)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"VALACYCLOVIR","company_name":"","drug_phase":"marketed","molecular_target":"Viral DNA polymerase","drug_class":"Nucleoside analogue","quality_score":80,"revenue":null,"mechanism":"Valacyclovir is an antiviral drug that inhibits viral DNA polymerase to treat herpes simplex and varicella-zoster viruses."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05796635","title":"An Investigation Into the Efficacy of Herpecin L at Reducing the Frequency and Severity of Cold Sores","phase":"NA","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Focus Consumer Healthcare","has_results":false},{"nct_id":"NCT06734728","title":"Post-marketing Study for the Evaluation of Profilm Cold Sores","phase":"NA","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"i+Med S.Coop.","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}